Abstract:Mutations in the BRCA1 or BRCA2 genes predispose to a wide spectrum of familial cancers. The functions of the proteins encoded by BRCA1 and BRCA2 remain to be elucidated, but their interaction and colocalization with hRAD51 suggest a role in homologous recombination and DNA double-strand break (DSB) repair. The role of BRCA1 and BRCA2 in the rejoining of ionizing radiation (IR)-induced DNA DSBs, which may represent a step in the overall process of repair, remains uncertain because recent reports provide conflicting results. Because elucidation of the role of these proteins in DNA DSB rejoining is important for their functional characterization, we reexamined this end point in cells with mutations in either BRCA1 or BRCA2. We show that two pancreatic carcinoma cell lines known to have either wild-type (BxPC3) or mutant forms (Capan-1) of BRCA2 rejoin IR-induced DNA DSBs to a similar extent following biphasic kinetics characterized by a fast and a slow component. Importantly, inactivation of DNA-dependent protein kinase (DNA-PK) by wortmannin generates similar shifts from the fast to the slow component of rejoining in BRCA2-proficient and BRCA2-deficient cells. This suggests that the functioning of either the fast, DNA-PK-dependent component or the slow, DNA-PK-independent component of rejoining is not affected by mutations in BRCA2. Also, a human breast cancer cell line with mutated BRCA1 shows normal rejoining of IR-induced DNA DSBs and levels of inhibition by wortmannin commensurate with the degree of DNA-PK inhibition. These observations fail to confirm a direct role for BRCA1 or BRCA2 in the rejoining of IR-induced DSBs in the genome of human tumor cells and, as a result, an involvement in nonhomologous end-joining. They are in line with similar observations with mutants deficient in genes implicated in homologous recombination and support the view that the radiosensitivity to killing of cells deficient in BRCA1 or BRCA2 derives from defects in this repair pathway.

Expression of BRC Repeats in Breast Cancer Cells Disrupts the BRCA2-Rad51 Complex and Leads to Radiation Hypersensitivity and Loss of G(2)/M Checkpoint Control.

Association of BRCA1 with the Hrad50-Hmre11-p95 Complex and the DNA Damage Response

Distinct binding of BRCA2 BRC repeats to RAD51 generates differential DNA damage sensitivity

A Variant of the Breast Cancer Type 2 Susceptibility Protein (BRC) Repeat is Essential for the RECQL5 Helicase to Interact with RAD51 Recombinase for Genome Stabilization

Involvement of BRCA2 Repeats in RAD51 Mediated DNA Repair

Deficiency of Human BRCA2 Leads to Impaired Homologous Recombination but Maintains Normal Nonhomologous End Joining

Involvement of Brca2 in DNA Repair.

BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage

Abstract 5603: Defining the functions of the BRCA2 BRC repeats in modulating RAD51 binding and activity

Nonhomologous End-Joining of Ionizing Radiation-Induced DNA Double-Stranded Breaks in Human Tumor Cells Deficient in BRCA1 or BRCA2.

The BRCA2-MEILB2-BRME1 complex governs meiotic recombination and impairs the mitotic BRCA2-RAD51 function in cancer cells

Mutations in the BRCT Binding Site of BRCA1 Result in Hyper-Recombination

RAP80-directed Tuning of BRCA1 Homologous Recombination Function at Ionizing Radiation-Induced Nuclear Foci.

Brcc36 is Essential for Ionizing Radiation-Induced Brca1 Phosphorylation and Nuclear Foci Formation

Hypersensitivity of Brca1-Deficient Mef to the Dna Interstrand Crosslinking Agent Mitomycin C is Associated with Defect in Homologous Recombination Repair and Aberrant S-Phase Arrest

A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.

BRCA2 regulates DMC1-mediated recombination through the BRC repeats

53BP1 Loss Rescues Embryonic Lethality but Not Genomic Instability of BRCA1 Total Knockout Mice

Homologous Recombination is Independently Regulated by BRCA1 and P53

Molecular Functions of BRCA1 in the DNA Damage Response

The Epistatic Relationship Between BRCA2 and the Other RAD51 Mediators in Homologous Recombination